What Researchers Did
Researchers reviewed 12 cases from literature and retrospectively evaluated one patient to describe a multimodal approach for managing invasive sino-orbital fungal infections.
What They Found
Based on a review of 12 cases and one retrospective patient evaluation, researchers found that retrobulbar Amphotericin B injection may be an effective adjunct. This adjunctive therapy, when combined with hyperbaric oxygen and parenteral antifungals, shows promise in controlling sino-orbital fungal infections.
What This Means for Canadian Patients
Canadian patients with severe sino-orbital fungal infections, particularly those who are immunocompromised, may benefit from this multimodal treatment approach. This could offer a less disfiguring alternative to orbital exenteration, potentially improving outcomes and quality of life.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
The primary limitation is the small sample size, consisting of a literature review of only 12 cases and a retrospective evaluation of a single patient, which limits generalizability.